This inventor holds 1 USPTO granted patent. Top assignee: Bioventures, LLC. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Guillermo Gonzalez, III: Innovator in Antibody-Nanoparticle Conjugates
Introduction
Guillermo Gonzalez, III is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of drug treatment through his innovative work on antibody-nanoparticle conjugates. His research focuses on addressing drug abuse and addiction, showcasing his commitment to improving public health.
Latest Patents
Gonzalez holds a patent for "Antibody-nanoparticle conjugates for the treatment of drug abuse." This invention relates to an antibody composition that includes antibodies conjugated to nanoparticles. The antibody composition may be utilized in methods to treat drug use, drug addiction, and the effects of drug use. His work in this area is crucial for developing new therapeutic strategies.
Career Highlights
Gonzalez is associated with Bioventures, LLC, where he applies his expertise in biotechnology and pharmaceuticals. His role at the company allows him to further his research and contribute to advancements in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Eric C. Peterson and Nisha Nanaware-Kharade. These partnerships enhance the scope and impact of his research efforts.
Conclusion
Guillermo Gonzalez, III is a dedicated inventor whose work on antibody-nanoparticle conjugates represents a significant advancement in the treatment of drug abuse. His contributions are vital for the ongoing fight against addiction and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile